Drugs.com
For patients, caregivers, and healthcare professionals requiring verified medication data, interaction checks, and pill identification.
Drugs.com Medication Guide
Snapshot
Who is Drugs.com?
Providing peer-reviewed medication information and identification tools to help patients and healthcare professionals manage drug safety.
Target audience
Portfolio
Free 2Last updated
Drugs.com Medication Guide
v3.3.0
3mo ago
Publisher DNA
What defines Drugs.com?
Publisher DNA
Primary focus
Medical reference and drug identification utilities
Scale
indie
Target audience
Patients, caregivers, and healthcare professionals requiring verified medication data, interaction checks, and pill identification.
Signature Patterns
- •Focus on peer-reviewed clinical data and pharmacist-verified information
- •Monetization via tiered subscriptions, ranging from monthly ad-removal to high-cost weekly utility access
- •Integration of specialized utility tools like AI image recognition and interaction checkers
- •Frequent update cadence to maintain database accuracy and app performance
Portfolio momentum
Maintained an active development cycle with 9 updates across both apps in the last 6 months, including a major release within the last 8 days.
Portfolio
What does Drugs.com ship?
Apps
3 apps analysed
Look up drug information, identify pills and manage your medications.
High-intent pill identifier utility
- Comprehensive medication interaction checking provides life-saving insights for patients managing multiple prescriptions and supplements
- Aggressive price increases for ad-free access frustrate long-term users who previously paid lower annual rates
Look up drug information, identify pills and manage your medications.
Highly-rated visual Pill Identifier tool
- Medication Management & Information
- Monetization & Pricing
- Medical professionals find the pill identification database useful for verifying medication accuracy during clinical shifts
- Incomplete pill database fails to identify common medications, leading users to label the app as useless
Single-market publisher, every app ships only to United States.
Based on 2 of 3 apps with localized market data, more coverage rolling in as scans complete · last scanned .
Americas (1)
- United States2 / 2
Core markets (2/2 apps)
User Sentiment
How do users feel about their apps?
2
Positive apps
0
Neutral / mixed
1
Negative apps
55/100
Avg sentiment score
Unlock the app dragging this portfolio down.
Access the full report for freeRivals
Who does Drugs.com compete with?
The rivals identified
Nemeses(1)
Both apps target healthcare professionals and students requiring medication information, creating direct competition for clinical reference utility.
Contenders(10)
Both apps target users needing medication identification, but PillCheckr offers visual search while the source relies on manual text input.
Both apps target healthcare professionals and students requiring offline medication data, creating direct competition for clinical reference utility.
Both apps target healthcare professionals and patients with medication reference tools, creating direct competition for clinical utility and drug information access.
Both apps target healthcare professionals and patients requiring offline medication identification, creating direct competition for clinical utility and drug reference data.
Both apps target healthcare professionals and consumers seeking drug information, creating direct competition for users needing quick medication reference tools.
Both apps target users needing medication identification, but the rival captures the free-tier audience with integrated tracking features that the source app lacks.
Both apps target healthcare professionals and patients requiring medication reference tools, with overlapping utility in pill identification and pharmacological data retrieval.
Both apps target users needing medication identification, but the rival offers a free, camera-based identification workflow that directly addresses the manual search limitations of the source app.
Both applications target users needing to identify loose medication via imprint, color, and shape, creating direct competition for the same clinical and consumer utility.
Both apps target healthcare professionals and consumers with offline-capable pill identification tools, creating direct competition for users in connectivity-restricted clinical environments.
Same space(23)
This app provides a visual-first alternative to manual search, using AI to identify pills based on appearance.
apodiscounter targets the pharmacy-fulfillment segment of the Drugs.com audience by offering direct online medication purchasing.
CVS Health captures the pharmacy-fulfillment segment of the Drugs.com audience through physical-digital integration.
Lilly Health™ serves the medication-adherence segment of the Drugs.com audience specifically for Eli Lilly patients.
Cute Pill targets the medication-adherence segment of the Drugs.com audience with a focus on simplicity.
gesund.de serves the pharmacy-fulfillment segment of the Drugs.com audience by connecting users to local German pharmacies.
GoodRx addresses the financial-utility segment of the Drugs.com audience by providing prescription pricing and discount coupons.
AI Medicine Identifier positions itself as an automated assistant for identifying loose pills via photo analysis.
Healthera targets the pharmacy-fulfillment segment of the Drugs.com audience by integrating with the NHS.
Blood Sugar - Diabetic Checker serves the chronic-condition management segment of the Drugs.com audience.
This app focuses on the educational needs of pharmacy students, providing a structured reference for the top 300 prescribed drugs.
Liki24 targets the pharmacy-fulfillment segment of the Drugs.com audience by acting as a European health marketplace.
PillEye targets the professional pharmacy workflow rather than consumer identification, using camera-based automation for inventory management.
Medisafe serves the same patient demographic but shifts the focus from one-time identification to long-term medication adherence and clinical safety.
mediteo targets the medication-adherence segment of the Drugs.com audience with a focus on privacy-first tracking.
mySugr targets the same medical-management audience by shifting from general drug info to specific diabetes-centric data logging.
MyTherapy serves the same patient base as Drugs.com but focuses on long-term adherence tracking rather than drug information reference.
PharmacyAI offers a comprehensive management suite that integrates AI-driven chat with interaction checking and adherence tools.
Pillo competes for the medication-adherence segment of the Drugs.com user base by prioritizing persistent alarm mechanics.
Publix Pharmacy targets the same pharmacy-utility segment as Drugs.com by digitizing the prescription-refill workflow.
TakeYourPills serves the same medication-tracking audience as Drugs.com but focuses on a simplified, all-in-one organizer interface.
WebMD acts as a broader health portal that includes pill identification as one of many standard utilities for symptom triage.
WebMD competes directly with Drugs.com by offering a similar medical-reference utility to drive ad-supported traffic.
The Analyst's Read
The bottom line on Drugs.com
Bottom line
Drugs.com is a high-authority medical publisher successfully translating a massive web presence into a specialized mobile portfolio. While their core reference app maintains exceptional user sentiment, the aggressive pricing strategy on utility-focused tools represents a significant pivot toward high-ARPU monetization.
Frequently asked questions
How many apps does Drugs.com publish?
What kind of apps does Drugs.com make?
What is Drugs.com's top app?
In how many countries are Drugs.com's apps available?
What fed this analysis
- Apps analyzed:
- 2
- With full intel:
- 2
- With overview:
- 2
- Website scraped:
- yes
- Social presence:
- yes
